157 related articles for article (PubMed ID: 16448988)
1. Is insulin resistance the cause of the metabolic syndrome?
Ferrannini E
Ann Med; 2006; 38(1):42-51. PubMed ID: 16448988
[TBL] [Abstract][Full Text] [Related]
2. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
Chan JC; Tong PC; Critchley JA
Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
[TBL] [Abstract][Full Text] [Related]
3. Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome?
Serné EH; de Jongh RT; Eringa EC; Ijzerman RG; de Boer MP; Stehouwer CD
Essays Biochem; 2006; 42():163-76. PubMed ID: 17144887
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance and the metabolic syndrome-a challenge of the new millennium.
Hauner H
Eur J Clin Nutr; 2002 Mar; 56 Suppl 1():S25-9. PubMed ID: 11965519
[TBL] [Abstract][Full Text] [Related]
5. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
[TBL] [Abstract][Full Text] [Related]
6. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
Chapman MJ; Sposito AC
Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
[TBL] [Abstract][Full Text] [Related]
7. Gestational diabetes, pregnancy hypertension, and late vascular disease.
Carpenter MW
Diabetes Care; 2007 Jul; 30 Suppl 2():S246-50. PubMed ID: 17596480
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
Cersosimo E; DeFronzo RA
Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
10. Vascular disease in the metabolic syndrome: do we need to target the microcirculation to treat large vessel disease?
Krentz AJ; Clough G; Byrne CD
J Vasc Res; 2009; 46(6):515-26. PubMed ID: 19571572
[TBL] [Abstract][Full Text] [Related]
11. A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians - the Chennai Urban Rural Epidemiology Study (CURES-38).
Mohan V; Sandeep S; Deepa M; Gokulakrishnan K; Datta M; Deepa R
Diabetes Obes Metab; 2007 May; 9(3):337-43. PubMed ID: 17391160
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome: multiple candidate genes, multiple environmental factors--multiple syndromes?
Nestel P
Int J Clin Pract Suppl; 2003 Mar; (134):3-9. PubMed ID: 12793592
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560
[TBL] [Abstract][Full Text] [Related]
14. The metabolic syndrome: metabolic changes with vascular consequences.
Wassink AM; Olijhoek JK; Visseren FL
Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
[TBL] [Abstract][Full Text] [Related]
15. Factor analysis of metabolic syndrome components in obese women.
Lafortuna CL; Adorni F; Agosti F; Sartorio A
Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):233-41. PubMed ID: 17600693
[TBL] [Abstract][Full Text] [Related]
16. The association of low-grade inflammation, urinary albumin, and insulin resistance with metabolic syndrome in nondiabetic Taiwanese.
Lee IT; Lee WJ; Huang CN; H-H Sheu W
Metabolism; 2007 Dec; 56(12):1708-13. PubMed ID: 17998025
[TBL] [Abstract][Full Text] [Related]
17. Evidence for distinct effects of GH and IGF-I in the metabolic syndrome.
Maison P; Balkau B; Souberbielle JC; Cunin P; Vol S; Macquin-Mavier I; Eschwège E;
Diabet Med; 2007 Sep; 24(9):1012-8. PubMed ID: 17535291
[TBL] [Abstract][Full Text] [Related]
18. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese.
Hsu LA; Ko YL; Wu S; Teng MS; Chou HH; Chang CJ; Chang PY
Metabolism; 2009 Jul; 58(7):983-8. PubMed ID: 19394054
[TBL] [Abstract][Full Text] [Related]
19. The metabolic syndrome: evolving evidence that thiazolidinediones provide rational therapy.
Wyne KL
Diabetes Obes Metab; 2006 Jul; 8(4):365-80. PubMed ID: 16776743
[TBL] [Abstract][Full Text] [Related]
20. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.
Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Walldius G; Hamsten A; Hellénius ML; Fisher RM
Eur Heart J; 2007 Nov; 28(21):2637-43. PubMed ID: 17766927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
